knowledge -WSS

knowledge

author：entertainment 2025-09-29 01:46:20 - browse：3

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Grail spinoff by Illumina should end disastrous merger attempt

explore

WSS

What to do when lifesaving products contribute to climate change

Readout Newsletter: The latest on Moderna, Apellis, and Merck

CRISPR gene editing developments we’re watching in 2024

Three trends to watch in biotech in 2024

Virtual care provider acquires bankrupt Pear's prescription apps

David Ricks of Eli Lilly: best biopharma CEO of 2023

hotspot

knowledge

entertainment

Affirmative action in medical school literally saved lives

Will the market for weight loss drugs really reach $100 billion?

Virginia high school admissions case could be legal follow

SEC charges former device maker CEO with $41 million fraud

The high cost of giving birth even with insurance

What don’t we know about an Alzheimer’s drug side effect?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

SEC charges former device maker CEO with $41 million fraud

Hepatitis C has a cure — but many Americans still lack access to it

Why health records don't always know when patients are dead

hotspot

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

What don’t we know about an Alzheimer’s drug side effect?

Takeda, Janssen join wearable maker to measure scratching

With clinical trial data readouts, here's how to spot spin

FDA investigates CAR

hotspot

Wikipedia

explore

explore